Literature DB >> 21900915

Paraoxonase-1 and clopidogrel efficacy.

Jordi Camps, Jorge Joven, Bharti Mackness, Michael Mackness, Dan Tawfik, Dragomir Draganov, Lucio G Costa, György Paragh, Ildikó Seres, Sven Horke, Richard James, Antonio Hernández, Srinivasa Reddy, Diana Shih, Mohamed Navab, Daniel Rochu, Michael Aviram.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21900915     DOI： 10.1038/nm.2386

Source DB:  PubMed          Journal:  Nat Med        ISSN： 1078-8956            Impact factor:   53.440


× No keyword cloud information.
  12 in total

1.  Mouse serum paraoxonase-1 lactonase activity is specific for medium-chain length fatty acid lactones.

Authors:  Philip W Connelly; Clive M Picardo; Philip M Potter; John F Teiber; Graham F Maguire; Dominic S Ng
Journal:  Biochim Biophys Acta       Date:  2010-10-29

2.  Human paraoxonases (PON1, PON2, and PON3) are lactonases with overlapping and distinct substrate specificities.

Authors:  Dragomir I Draganov; John F Teiber; Audrey Speelman; Yoichi Osawa; Roger Sunahara; Bert N La Du
Journal:  J Lipid Res       Date:  2005-03-16       Impact factor: 5.922

3.  'A'-esterase activity in the lipoprotein fraction of sheep serum.

Authors:  M I Mackness; C H Walker
Journal:  Biochem Pharmacol       Date:  1981-04-15       Impact factor: 5.858

4.  Paraoxon hydrolysis in human serum mediated by a genetically variable arylesterase and albumin.

Authors:  J Ortigoza-Ferado; R J Richter; S K Hornung; A G Motulsky; C E Furlong
Journal:  Am J Hum Genet       Date:  1984-03       Impact factor: 11.025

5.  Paraoxonase-1 is a major determinant of clopidogrel efficacy.

Authors:  Heleen J Bouman; Edgar Schömig; Jochem W van Werkum; Janna Velder; Christian M Hackeng; Christoph Hirschhäuser; Christopher Waldmann; Hans-Günther Schmalz; Jurriën M ten Berg; Dirk Taubert
Journal:  Nat Med       Date:  2010-12-19       Impact factor: 53.440

6.  Calcium-dependent human serum homocysteine thiolactone hydrolase. A protective mechanism against protein N-homocysteinylation.

Authors:  H Jakubowski
Journal:  J Biol Chem       Date:  2000-02-11       Impact factor: 5.157

7.  Quantification of human serum paraoxonase by enzyme-linked immunoassay: population differences in protein concentrations.

Authors:  M C Blatter Garin; C Abbott; S Messmer; M Mackness; P Durrington; D Pometta; R W James
Journal:  Biochem J       Date:  1994-12-01       Impact factor: 3.857

8.  Structure and evolution of the serum paraoxonase family of detoxifying and anti-atherosclerotic enzymes.

Authors:  Michal Harel; Amir Aharoni; Leonid Gaidukov; Boris Brumshtein; Olga Khersonsky; Ran Meged; Hay Dvir; Raimond B G Ravelli; Andrew McCarthy; Lilly Toker; Israel Silman; Joel L Sussman; Dan S Tawfik
Journal:  Nat Struct Mol Biol       Date:  2004-04-18       Impact factor: 15.369

Review 9.  The paraoxonases: role in human diseases and methodological difficulties in measurement.

Authors:  Jordi Camps; Judit Marsillach; Jorge Joven
Journal:  Crit Rev Clin Lab Sci       Date:  2009       Impact factor: 6.250

10.  In vivo administration of BL-3050: highly stable engineered PON1-HDL complexes.

Authors:  Leonid Gaidukov; Dganit Bar; Shiri Yacobson; Esmira Naftali; Olga Kaufman; Rinat Tabakman; Dan S Tawfik; Etgar Levy-Nissenbaum
Journal:  BMC Clin Pharmacol       Date:  2009-11-17
View more
  7 in total

Review 1.  Pharmacogenetics of paraoxonase activity: elucidating the role of high-density lipoprotein in disease.

Authors:  Daniel Seung Kim; Judit Marsillach; Clement E Furlong; Gail P Jarvik
Journal:  Pharmacogenomics       Date:  2013-09       Impact factor: 2.533

2.  Relationships between PON1 Q192R polymorphism and clinical outcome of antiplatelet treatment after percutaneous coronary intervention: a meta-analysis.

Authors:  Ping Li; Shu-Hong Bu; Xiao-Tong Lu; Li-Xia Li; A-Jing Xu; Yue-Nian Tang; Jian Zhang
Journal:  Mol Biol Rep       Date:  2014-07-01       Impact factor: 2.316

3.  Paraoxonases-1, -2 and -3: What are their functions?

Authors:  Clement E Furlong; Judit Marsillach; Gail P Jarvik; Lucio G Costa
Journal:  Chem Biol Interact       Date:  2016-05-26       Impact factor: 5.192

Review 4.  Recent advances in the pharmacogenetics of clopidogrel.

Authors:  Thomas Cuisset; Pierre-Emmanuel Morange; Marie-Christine Alessi
Journal:  Hum Genet       Date:  2011-12-30       Impact factor: 4.132

Review 5.  Human paraoxonase-1 (PON1): Gene structure and expression, promiscuous activities and multiple physiological roles.

Authors:  Mike Mackness; Bharti Mackness
Journal:  Gene       Date:  2015-05-09       Impact factor: 3.688

6.  Human valacyclovir hydrolase/biphenyl hydrolase-like protein is a highly efficient homocysteine thiolactonase.

Authors:  Judit Marsillach; Stephanie M Suzuki; Rebecca J Richter; Matthew G McDonald; Peter M Rademacher; Michael J MacCoss; Edward J Hsieh; Allan E Rettie; Clement E Furlong
Journal:  PLoS One       Date:  2014-10-15       Impact factor: 3.240

7.  Association between Paraoxonase-1 p.Q192R Polymorphism and Coronary Artery Disease susceptibility in the Colombian Population.

Authors:  David Corredor-Orlandelli; Santiago Sambracos-Parrado; Santiago Mantilla-García; Josué Tovar-Tirado; Valentina Vega-Ramírez; Santiago David Mendoza-Ayús; Laura Catalina Peña; María Fernanda Leal; Juliana Rodríguez-Carrillo; Juanita León-Torres; Juan Mauricio Pardo-Oviedo; Katherine Parra Abaunza; Nora Contreras Contreras Bravo; Oscar Ortega-Recalde; Dora Janeth Fonseca Mendoza
Journal:  Vasc Health Risk Manag       Date:  2021-11-03
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.